Tacrolimus ameliorates pulmonary hypertension associated with pulmonary fibrosis via modulation of vascular remodeling.
- DOI
- 10.3389/fphar.2026.1880903
- Published
- 2026
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1880903,
title = {Tacrolimus ameliorates pulmonary hypertension associated with pulmonary fibrosis via modulation of vascular remodeling.},
author = {Liu X and Chen Q and Hu Y and Liu Z and Yang Z and Yu J and Li H and Chen R and Shao C and Wang S and Yang C and Li X and Huang H},
year = {2026},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2026.1880903},
url = {https://doi.org/10.3389/fphar.2026.1880903}
}RIS
TY - JOUR TI - Tacrolimus ameliorates pulmonary hypertension associated with pulmonary fibrosis via modulation of vascular remodeling. AU - Liu X AU - Chen Q AU - Hu Y AU - Liu Z AU - Yang Z AU - Yu J AU - Li H AU - Chen R AU - Shao C AU - Wang S AU - Yang C AU - Li X AU - Huang H PY - 2026 JO - Frontiers in pharmacology DO - 10.3389/fphar.2026.1880903 UR - https://doi.org/10.3389/fphar.2026.1880903 ER -
APA
X, L., Q, C., Y, H., Z, L., Z, Y., J, Y., H, L., R, C., C, S., S, W., C, Y., X, L., & H, H. (2026). Tacrolimus ameliorates pulmonary hypertension associated with pulmonary fibrosis via modulation of vascular remodeling.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1880903